The global fluorocooled RF ablation market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market can be attributed to the increasing number of patients suffering from chronic pain and other diseases such as cancer, which are treated with fluorocooled RF ablation. The increasing number of hospitals and clinics offering this treatment is also driving the growth of this market.
The global fluorocooled RF ablation market by type is segmented into dual fluorocooled RF ablation and single fluorocooled RF ablation. Dual fluorocooled RF ablation accounted for a share of more than 50% in 2017, owing to its higher efficacy in treating chronic pain conditions such as sciatica and herniated discs. Single-fluorocooled RF ablation has been gaining traction due to its lower cost compared with dual-fluorocooled RF ablation treatments, which are expensive owing to their use of two probes for treatment purposes.
-The global RF ablation market is expected to grow at a CAGR of 6.5% from 2018 to 2023.
-Increasing prevalence of chronic diseases such as diabetes and obesity are driving the growth of the global RF ablation market.
-Increasing number of hospitals and clinics offering RF ablation procedures is also driving the growth of the global RF ablation market.
Industry Growth Insights published a new data on “Fluid-cooled RF Ablation Market”. The research report is titled “Fluid-cooled RF Ablation Market research by Types (Dual Fluid-cooled RF Ablation, Others), By Applications (Surgery, Pain Management, Others), By Players/Companies Medtronic, Biosense Webster, St. Jude Medical, Boston Scientific Corporation, CONMED Corporation, AngioDynamics, AtriCure, Smith & Nephew, Olympus Corporation, Galil Medical, Cosman Medical, Stryker”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Fluid-cooled RF Ablation Market Research Report
By Type
Dual Fluid-cooled RF Ablation, Others
By Application
Surgery, Pain Management, Others
By Companies
Medtronic, Biosense Webster, St. Jude Medical, Boston Scientific Corporation, CONMED Corporation, AngioDynamics, AtriCure, Smith & Nephew, Olympus Corporation, Galil Medical, Cosman Medical, Stryker
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
Global Fluid-cooled RF Ablation Market Report Segments:
The global Fluid-cooled RF Ablation market is segmented on the basis of:
Types
Dual Fluid-cooled RF Ablation, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Surgery, Pain Management, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Medtronic
- Biosense Webster
- St. Jude Medical
- Boston Scientific Corporation
- CONMED Corporation
- AngioDynamics
- AtriCure
- Smith & Nephew
- Olympus Corporation
- Galil Medical
- Cosman Medical
- Stryker
Highlights of The Fluid-cooled RF Ablation Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Dual Fluid-cooled RF Ablation
- Others
- By Application:
- Surgery
- Pain Management
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Fluid-cooled RF Ablation Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Fluid-cooled RF ablation is a minimally invasive treatment for cancer that uses radiofrequency energy to destroy tumor cells. The technology works by using a fluid-cooled probe to target and heat up the tumor while circulating coolant around it, killing the cells.
Some of the key players operating in the fluid-cooled rf ablation market are Medtronic, Biosense Webster, St. Jude Medical, Boston Scientific Corporation, CONMED Corporation, AngioDynamics, AtriCure, Smith & Nephew, Olympus Corporation, Galil Medical, Cosman Medical, Stryker.
The fluid-cooled rf ablation market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Fluid-cooled RF Ablation Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Fluid-cooled RF Ablation Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Fluid-cooled RF Ablation Market - Supply Chain
4.5. Global Fluid-cooled RF Ablation Market Forecast
4.5.1. Fluid-cooled RF Ablation Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Fluid-cooled RF Ablation Market Size (000 Units) and Y-o-Y Growth
4.5.3. Fluid-cooled RF Ablation Market Absolute $ Opportunity
5. Global Fluid-cooled RF Ablation Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Fluid-cooled RF Ablation Market Size and Volume Forecast by Type
5.3.1. Dual Fluid-cooled RF Ablation
5.3.2. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Fluid-cooled RF Ablation Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Fluid-cooled RF Ablation Market Size and Volume Forecast by Application
6.3.1. Surgery
6.3.2. Pain Management
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Fluid-cooled RF Ablation Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Fluid-cooled RF Ablation Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Fluid-cooled RF Ablation Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Fluid-cooled RF Ablation Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Fluid-cooled RF Ablation Demand Share Forecast, 2019-2026
9. North America Fluid-cooled RF Ablation Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Fluid-cooled RF Ablation Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Fluid-cooled RF Ablation Market Size and Volume Forecast by Application
9.4.1. Surgery
9.4.2. Pain Management
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Fluid-cooled RF Ablation Market Size and Volume Forecast by Type
9.7.1. Dual Fluid-cooled RF Ablation
9.7.2. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Fluid-cooled RF Ablation Demand Share Forecast, 2019-2026
10. Latin America Fluid-cooled RF Ablation Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Fluid-cooled RF Ablation Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Fluid-cooled RF Ablation Market Size and Volume Forecast by Application
10.4.1. Surgery
10.4.2. Pain Management
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Fluid-cooled RF Ablation Market Size and Volume Forecast by Type
10.7.1. Dual Fluid-cooled RF Ablation
10.7.2. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Fluid-cooled RF Ablation Demand Share Forecast, 2019-2026
11. Europe Fluid-cooled RF Ablation Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Fluid-cooled RF Ablation Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Fluid-cooled RF Ablation Market Size and Volume Forecast by Application
11.4.1. Surgery
11.4.2. Pain Management
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Fluid-cooled RF Ablation Market Size and Volume Forecast by Type
11.7.1. Dual Fluid-cooled RF Ablation
11.7.2. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Fluid-cooled RF Ablation Demand Share, 2019-2026
12. Asia Pacific Fluid-cooled RF Ablation Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Fluid-cooled RF Ablation Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Fluid-cooled RF Ablation Market Size and Volume Forecast by Application
12.4.1. Surgery
12.4.2. Pain Management
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Fluid-cooled RF Ablation Market Size and Volume Forecast by Type
12.7.1. Dual Fluid-cooled RF Ablation
12.7.2. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Fluid-cooled RF Ablation Demand Share, 2019-2026
13. Middle East & Africa Fluid-cooled RF Ablation Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Fluid-cooled RF Ablation Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Fluid-cooled RF Ablation Market Size and Volume Forecast by Application
13.4.1. Surgery
13.4.2. Pain Management
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Fluid-cooled RF Ablation Market Size and Volume Forecast by Type
13.7.1. Dual Fluid-cooled RF Ablation
13.7.2. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Fluid-cooled RF Ablation Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Fluid-cooled RF Ablation Market: Market Share Analysis
14.2. Fluid-cooled RF Ablation Distributors and Customers
14.3. Fluid-cooled RF Ablation Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Medtronic
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Biosense Webster
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. St. Jude Medical
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Boston Scientific Corporation
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. CONMED Corporation
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. AngioDynamics
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. AtriCure
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Smith & Nephew
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Olympus Corporation
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Galil Medical
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Cosman Medical
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Stryker
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
